Boreal Genomics

📍 Vancouver, Canada🗓 Founded 2007👥 3 employees💰 Last funded Sep 2020
Biotechnology Research🌐 borealgenomics.com
Website LinkedIn
At Boreal, we are committed to improving cancer patient care through development of research tools and diagnostic tests based on monitoring of circulating tumor DNA in plasma. Boreal’s OnTarget™ platform performs highly sensitive mutation detection to enable accurate tumor profiling and real-time monitoring of tumor evolution from cell-free DNA in plasma. The OnTarget™ assay is available as a research-use service to reveal tumor mutations that are undetectable with other methods and may help guide selection of therapy, improve clinical trial efficiency, and accelerate drug development programs.
3
Total investors
1
Early stage
0
Mid stage
1
Late stage
2007
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
Canada
2
United States
1
Investor activity2008–2020 · investors recorded per year
200812015120201
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Boreal Genomics?
Boreal Genomics has 3 investors on record on gritt.io, including 1 early-stage backers and 1 late-stage investors.
When did Boreal Genomics last raise funding?
The most recent investment in Boreal Genomics recorded on gritt.io was in September 2020.
When was Boreal Genomics founded?
Boreal Genomics was founded in 2007.
What industry is Boreal Genomics in?
Boreal Genomics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Boreal Genomics based?
Boreal Genomics is headquartered in Vancouver, Canada.